Navigation Links
Puritan Awarded U.S. Patent for High-Performance HydraFlock® Swab

Guilford, Maine (PRWEB) December 12, 2012

Puritan Medical Products Co., LLC, an American manufacturer of single-use medical products for the global market, will be awarded a United States patent for its high-performance HydraFlock® swab on Dec. 18, 2012.

Puritan’s latest U.S. patent (No. 8334134) is both for inventing the innovative HydraFlock® product itself as well as for the unique manufacturing method involved. Puritan’s HydraFlock® swab produces superior sample collection, rapid elution, and increased test sensitivity by combining a unique microstructure with innovative fibers.

Puritan was previously awarded a Canadian patent for the HydraFlock® swab as a product and for the manufacturing process in September. Patents for the HydraFlock® swab also are pending in other countries throughout the world.

“The HydraFlock® swab is a high-performance product and we’ve always believed that our manufacturing process is unlike any other,” said Puritan Executive Vice President of Sales Timothy Templet. “It is great to have these beliefs affirmed by the U.S. Patent and Trademark Office. We look forward to obtaining patents in other countries and to bringing this product line to new markets and competing globally.”

Puritan Medical Products has expanded rapidly over the last few years as a direct result of the company’s effort to meet the evolving needs of the healthcare, forensic, critical environment, food safety, and drug manufacturing industries.

Puritan now manufactures more than 35 types of swabs including the PurFlock® and HydraFlock® swabs, both manufactured in Guilford, Maine by American workers.

About Puritan
Puritan Medical Products Co., LLC is North America’s largest manufacturer of single-use medical products and diagnostic products. All Puritan products are manufactured at their Guilford, Maine, U.S. facility, which includes custom media manufacturing and compounding capability to meet a multitude of customer needs. Puritan operates a state-of-the-art microbiology laboratory that conforms to stringent U.S. quality system regulations. This lab is where all Puritan’s research and development as well as product testing, approval, and release take place.

Read the full story at

Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

Related biology technology :

1. Crisalix Awarded as a Leading Life Science Company that is Revolutionizing the Medical Industry
2. Plant Sensory Systems Awarded $1.8 Million from ARPA-E to Engineer Beets for Biofuel
3. Ben-Gurion University awarded $6.5 million grant to develop nano thin infrared night vision glasses
4. Arecor Awarded Biomedical Catalyst Funding Towards £1.3 Million Project
5. WaferGen Bio-systems Awarded 1 Million Euro Grant by the Luxembourg Government to expand its European Operations
6. Stanford faculty awarded $2.2 million for innovative energy research
7. CSL Biotherapies Awarded US Government Contract for Influenza Pandemic Preparedness and Response
8. Avery-Landsteiner Prize for Immunology Awarded to Alain Fischer of Paris, France, by German Society for Immunology
9. Trellis Bioscience Awarded SBIR Grant to Advance CMV Program
10. Astrix Technology Group Awarded Department of Homeland Security BioWatch Laboratory Staffing Contract
11. Ekahau - A Preferred Provider of Real-Time Location Solutions - Is Awarded an Agreement with the Premier Healthcare Alliance
Post Your Comments:
(Date:6/23/2016)... Houston Methodist Willowbrook Hospital has signed ... to serve as their official health care provider. ... will provide sponsorship support, athletic training services, and ... volunteers, athletes and families. "We are ... and to bring Houston Methodist quality services and ...
(Date:6/23/2016)... 23, 2016   EpiBiome , a precision microbiome ... in debt financing from Silicon Valley Bank (SVB). The ... to advance its drug development efforts, as well as ... "SVB has been an incredible strategic partner to ... traditional bank would provide," said Dr. Aeron Tynes ...
(Date:6/23/2016)... 2016 Apellis Pharmaceuticals, Inc. today announced ... of its complement C3 inhibitor, APL-2. The trials ... dose studies designed to assess the safety, tolerability, ... in healthy adult volunteers. Forty subjects ... single dose (ranging from 45 to 1,440mg) or ...
(Date:6/23/2016)... ... June 23, 2016 , ... ClinCapture, the only free ... and will showcase its product’s latest features from June 26 to June 30, ... poster on Disrupting Clinical Trials in The Cloud during the conference. DIA ...
Breaking Biology Technology:
(Date:4/15/2016)... 15, 2016 Research and ... Biometrics Market 2016-2020,"  report to their offering.  , ... , ,The global gait biometrics market is expected ... the period 2016-2020. Gait analysis generates ... be used to compute factors that are not ...
(Date:3/31/2016)... 2016  Genomics firm Nabsys has completed a financial ... Bready , M.D., who returned to the company in ... leadership team, including Chief Technology Officer, John Oliver ... Nurnberg and Vice President of Software and Informatics, ... Dr. Bready served as CEO of Nabsys from ...
(Date:3/22/2016)... PROVO and SANDY, Utah ... (NSO), which operates the highest sample volume laboratory in ... Tute Genomics and UNIConnect, leaders in clinical sequencing informatics ... the launch of a project to establish the informatics ... NSO has been contracted by the ...
Breaking Biology News(10 mins):